Healthpeak Properties, Inc. (DOC) Revenue History
Annual and quarterly revenue from 2011 to present
DOC Revenue Over Time (2011–2025)
DOC Revenue Growth History
11 of 14 years with positive growth- FY2011 revenue growth
- N/A
- FY2012 revenue growth
- +11.0%
- FY2013 revenue growth
- +11.7%
- FY2014 revenue growth
- -22.1%
- FY2015 revenue growth
- +18.6%
- FY2016 revenue growth
- +9.7%
- FY2017 revenue growth
- -13.2%
- FY2018 revenue growth
- -35.5%
- FY2019 revenue growth
- +4.1%
- FY2020 revenue growth
- +32.6%
- FY2021 revenue growth
- +15.3%
- FY2022 revenue growth
- +8.7%
- FY2023 revenue growth
- +5.8%
- FY2024 revenue growth
- +23.8%
- FY2025 revenue growth
- +4.5%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $753.0M | +7.1% |
| Q4 2025 | $719.4M | +3.1% |
| Q3 2025 | $705.9M | +0.8% |
| Q2 2025 | $694.3M | -0.2% |
| Q1 2025 | $702.9M | +15.9% |
| Q4 2024 | $698.0M | +26.1% |
| Q3 2024 | $700.4M | +25.9% |
| Q2 2024 | $695.5M | +27.5% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
DOC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
DOC Revenue Analysis (2011–2025)
Current Revenue & Growth
As of June 20, 2026, Healthpeak Properties, Inc. (DOC) generated trailing twelve-month (TTM) revenue of $2.87 billion, reflecting solid growth of +7.1% year-over-year. The most recent quarter (Q1 2026) recorded $753.0 million in revenue, up 4.7% sequentially.
Historical Growth Trajectory
DOC's 5-year compound annual growth rate (CAGR) stands at +11.4%, indicating consistent double-digit revenue growth. The 3-year CAGR of +11.0% is in line with the 5-year average, suggesting consistent growth. Healthpeak Properties, Inc.'s highest annual revenue of $2.82 billion was recorded in 2025, an all-time high.
Revenue by Segment
DOC's revenue is primarily driven by Outpatient Medical Buildings (47%), Lab (31%), and Senior Housing (22%). The diversified mix across segments reduces dependence on any single product line, which can support more resilient revenue in downturns.
Peer Comparison
Compared to Real Estate sector peers — including VTR (+20.7% YoY), WELL (+38.3% YoY), and HR (-7.4% YoY) — DOC has underperformed the peer group in revenue growth. Compare DOC vs VTR →
DOC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| DOCCurrent | $2.9B | +7.1% | +11.4% | 19.3% | |
 VTR | $5.8B | +20.7% | +9.0% | 14.2% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 HR | $1.2B | -7.4% | +9.9% | 8.0% | |
 OHI | $1.2B | +14.2% | +6.1% | 62.6% | |
 SABR | $2.8B | -4.1% | +15.7% | 12.7% |
DOC Historical Revenue Data (2011–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.82B | +4.5% | $634.5M | 22.5% | $544.1M | 19.3% |
| 2024 | $2.70B | +23.8% | $1.63B | 60.2% | $471.2M | 17.4% |
| 2023 | $2.18B | +5.8% | $1.28B | 58.6% | $433.9M | 19.9% |
| 2022 | $2.06B | +8.7% | $1.20B | 58.1% | $356.6M | 17.3% |
| 2021 | $1.90B | +15.3% | $1.12B | 59.2% | $340.3M | 17.9% |
| 2020 | $1.64B | +32.6% | $862.3M | 52.4% | $215.1M | 13.1% |
| 2019 | $1.24B | +4.1% | $835.1M | 67.3% | $306.9M | 24.7% |
| 2018 | $1.19B | -35.5% | $812.7M | 68.2% | $311.3M | 26.1% |
| 2017 | $1.85B | -13.2% | $1.18B | 64.0% | $558.6M | 30.2% |
| 2016 | $2.13B | +9.7% | $1.39B | 65.3% | $719.2M | 33.8% |
| 2015 | $1.94B | +18.6% | $1.33B | 68.5% | $728.9M | 37.6% |
| 2014 | $1.64B | -22.1% | $1.26B | 76.7% | $718.8M | 43.9% |
| 2013 | $2.10B | +11.7% | $1.80B | 85.8% | $1.28B | 60.7% |
| 2012 | $1.88B | +11.0% | $1.60B | 85.1% | $1.18B | 62.6% |
| 2011 | $1.69B | - | $1.48B | 87.1% | $1.03B | 61.0% |
Full Stock Analysis
Deep dive into DOC consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
DOC — Frequently Asked Questions
Quick answers to the most common questions about buying DOC stock.
Is DOC's revenue growth accelerating or slowing?
DOC revenue growth is holding steady at +7.1% year-over-year. TTM revenue is $2.9B. The current growth rate closely tracks the 5-year CAGR of +11.4%, signalling consistent execution.
What is DOC's revenue history from 2011 to 2026?
Healthpeak Properties, Inc. (DOC) revenue history spans 2011 to 2026. TTM revenue as of 2026 is $2.9B, growing at +7.1% YoY. The 5-year CAGR is +11.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is DOC's long-term revenue growth rate (CAGR)?
Healthpeak Properties, Inc.'s 5-year revenue CAGR of +11.4% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +7.1% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for DOC.
Why does DOC's quarterly revenue fluctuate?
DOC quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Healthpeak Properties, Inc.'s revenue data from 2011 to 2026 shows full historical quarterly detail on this page.
How is DOC's revenue distributed by segment?
DOC reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does DOC's revenue compare to industry peers?
Healthpeak Properties, Inc. (DOC) with TTM revenue of $2.9B and +7.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.